Benchmark Downgrades Transphorm to Hold
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst David Williams has downgraded Transphorm (NASDAQ:TGAN) from Buy to Hold, indicating a change in the stock's outlook.

January 16, 2024 | 8:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Transphorm's stock rating has been downgraded by Benchmark analyst David Williams from Buy to Hold, suggesting a more cautious view on the stock's future performance.
Downgrades by analysts can lead to a negative perception among investors, potentially causing a short-term decline in the stock price. The downgrade from Buy to Hold suggests that the analyst sees limited upside potential or increased risk in the stock's near-term outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100